These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16310381

  • 1. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
    Percy MJ, Crowley LJ, Roper D, Vulliamy TJ, Layton DM, Barber MJ.
    Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
    [Abstract] [Full Text] [Related]

  • 2. Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase.
    Percy MJ, Crowley LJ, Davis CA, McMullin MF, Savage G, Hughes J, McMahon C, Quinn RJ, Smith O, Barber MJ, Lappin TR.
    Br J Haematol; 2005 Jun; 129(6):847-53. PubMed ID: 15953014
    [Abstract] [Full Text] [Related]

  • 3. Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.
    Davis CA, Crowley LJ, Barber MJ.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):233-44. PubMed ID: 15488472
    [Abstract] [Full Text] [Related]

  • 4. The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site.
    Bewley MC, Davis CA, Marohnic CC, Taormina D, Barber MJ.
    Biochemistry; 2003 Nov 18; 42(45):13145-51. PubMed ID: 14609324
    [Abstract] [Full Text] [Related]

  • 5. Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D.
    Davis CA, Barber MJ.
    Arch Biochem Biophys; 2004 May 15; 425(2):123-32. PubMed ID: 15111120
    [Abstract] [Full Text] [Related]

  • 6. Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.
    Percy MJ, Lappin TR.
    Br J Haematol; 2008 May 15; 141(3):298-308. PubMed ID: 18318771
    [Abstract] [Full Text] [Related]

  • 7. A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia.
    Kedar PS, Warang P, Nadkarni AH, Colah RB, Ghosh K.
    Blood Cells Mol Dis; 2008 May 15; 40(3):323-7. PubMed ID: 17964195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.
    Fermo E, Bianchi P, Vercellati C, Marcello AP, Garatti M, Marangoni O, Barcellini W, Zanella A.
    Blood Cells Mol Dis; 2008 May 15; 41(1):50-5. PubMed ID: 18343696
    [Abstract] [Full Text] [Related]

  • 10. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
    Roma GW, Crowley LJ, Barber MJ.
    Arch Biochem Biophys; 2006 Aug 01; 452(1):69-82. PubMed ID: 16814740
    [Abstract] [Full Text] [Related]

  • 11. Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding.
    Percy MJ, Crowley LJ, Boudreaux J, Barber MJ.
    Arch Biochem Biophys; 2006 Mar 01; 447(1):59-67. PubMed ID: 16469290
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytochrome b5 reductase: role of the si-face residues, proline 92 and tyrosine 93, in structure and catalysis.
    Marohnic CC, Crowley LJ, Davis CA, Smith ET, Barber MJ.
    Biochemistry; 2005 Feb 22; 44(7):2449-61. PubMed ID: 15709757
    [Abstract] [Full Text] [Related]

  • 16. [Molecular analysis of the structure of the mutant NADH-cytochrome b5 reductase gene causing methemoglobinemia].
    Kobayashi Y.
    Fukuoka Igaku Zasshi; 1990 Jan 22; 81(1):41-7. PubMed ID: 2323714
    [Abstract] [Full Text] [Related]

  • 17. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.
    Roma GW, Crowley LJ, Davis CA, Barber MJ.
    Biochemistry; 2005 Oct 18; 44(41):13467-76. PubMed ID: 16216070
    [Abstract] [Full Text] [Related]

  • 18. A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia.
    Nussenzveig RH, Lingam HB, Gaikwad A, Zhu Q, Jing N, Prchal JT.
    Haematologica; 2006 Nov 18; 91(11):1542-5. PubMed ID: 17082011
    [Abstract] [Full Text] [Related]

  • 19. Prenatal diagnosis of recessive congenital methaemoglobinaemia type II: novel mutation in the NADH-cytochrome b5 reductase gene leading to stop codon read-through.
    Leroux A, Leturcq F, Deburgrave N, Szajnert MF.
    Eur J Haematol; 2005 May 18; 74(5):389-95. PubMed ID: 15813912
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients.
    Maran J, Guan Y, Ou CN, Prchal JT.
    Haematologica; 2005 May 18; 90(5):687-9. PubMed ID: 15921385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.